Levorphanol Tartrate
Payments companies reported to CMS as associated with Levorphanol Tartrate. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Levorphanol Tartrate, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Levorphanol Tartrate
These are the largest totals companies reported as associated with Levorphanol Tartrate. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jeffrey Weber | Kinston, NC | Physician Assistant | $466.54 |
| Paul Kramm | Baton Rouge, LA | Pain Medicine (Physical Medicine & Rehabilitation) | $465.23 |
| James Rho | Rancho Cucamonga, CA | Interventional Pain Medicine | $462.67 |
| Damon Kimes | Roswell, GA | Pain Medicine | $425.88 |
| Eric Batangan | Olympia, WA | Physician Assistant | $379.89 |
| George Perdikis | Ridgecrest, CA | $372.82 | |
| Erin Henderson | Olympia, WA | Nurse Practitioner | $364.72 |
| William Lichtenfeld | Johns Creek, GA | Pain Medicine (Physical Medicine & Rehabilitation) | $345.42 |
| Caryn Axtell-Kelly | Chino, CA | Medical | $345.15 |
| Steve Lee | Slidell, LA | Interventional Pain Medicine | $330.12 |
Prescribed Levorphanol Tartrate?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.